NASDAQ : IVF
INVO Fertility, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.5361 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.56M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.47M |
| Enterprise Value | 2.66M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.19M |
| Shares Outstanding | 1.19M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +58.26% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 8.21% |
| Float | 1.19M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| Forward PS | 0.38 |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.71 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.51 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -72.70% |
| Return on Assets (ROA) | -16.41% |
| Return on Invested Capital (ROIC) | -24.56% |
| Return on Capital Employed (ROCE) | -30.69% |
| Weighted Average Cost of Capital (WACC) | 16.07% |
| Revenue Per Employee | $179,312 |
| Profits Per Employee | -$208,530 |
| Employee Count | 42 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 21.01 |
Taxes
| Measure | Value |
|---|
| Income Tax | -94,217 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -97.64% |
| 50-Day Moving Average | 3.30 |
| 200-Day Moving Average | 9.11 |
| Relative Strength Index (RSI) | 31.33 |
| Average Volume (20 Days) | 31,740 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 26,478 |
| Short Previous Month | 50,118 |
| Short % of Shares Out | 2.22% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 0.19 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 7.53M |
| Gross Profit | 2.66M |
| Operating Income | -5.93M |
| Pretax Income | -7.05M |
| Net Income | -8.76M |
| EBITDA | -5.37M |
| EBIT | -5.93M |
| Loss Per Share | -$33.37 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.73M |
| Total Debt | 3.92M |
| Net Cash | -188,753 |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 16.49M |
| Book Value Per Share | 28.05 |
| Working Capital | -1.92M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -4.77M |
| Capital Expenditures | -39,456 |
| Depreciation & Amortization | 561,437 |
| Net Borrowing | -232,800 |
| Free Cash Flow | -4.81M |
| FCF Per Share | -$4.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | 35.28% |
| Operating Margin | -78.72% |
| Pretax Margin | -93.55% |
| Profit Margin | -92.30% |
| EBITDA Margin | -71.26% |
| EBIT Margin | -78.72% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1,612.60% |
| FCF Yield | -211.07% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 56.07% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 30, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -5.54 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |